X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11449) 11449
Publication (1431) 1431
Book Chapter (117) 117
Book Review (92) 92
Conference Proceeding (29) 29
Dissertation (24) 24
Newsletter (16) 16
Magazine Article (8) 8
Newspaper Article (5) 5
Book / eBook (4) 4
Government Document (3) 3
Reference (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7791) 7791
tumor-infiltrating lymphocytes (5782) 5782
oncology (5058) 5058
index medicus (4797) 4797
female (4317) 4317
lymphocytes, tumor-infiltrating - immunology (4103) 4103
immunotherapy (3418) 3418
cancer (3154) 3154
animals (2815) 2815
male (2796) 2796
immunology (2770) 2770
middle aged (2705) 2705
aged (2291) 2291
lymphocytes (2101) 2101
prognosis (2087) 2087
adult (2000) 2000
mice (1889) 1889
expression (1813) 1813
tumors (1575) 1575
melanoma (1569) 1569
lymphocytes, tumor-infiltrating - pathology (1473) 1473
immunohistochemistry (1414) 1414
t cells (1396) 1396
survival (1334) 1334
lymphocytes, tumor-infiltrating - metabolism (1264) 1264
t-cells (1168) 1168
t-lymphocytes - immunology (1114) 1114
dendritic cells (1091) 1091
cd8-positive t-lymphocytes - immunology (1059) 1059
medicine, research & experimental (1043) 1043
carcinoma (1038) 1038
melanoma - immunology (1031) 1031
chemotherapy (973) 973
breast cancer (972) 972
metastatic melanoma (950) 950
aged, 80 and over (935) 935
care and treatment (922) 922
research (906) 906
neoplasms - immunology (902) 902
t-lymphocytes, cytotoxic - immunology (878) 878
pathology (871) 871
analysis (849) 849
article (847) 847
tumor cells, cultured (847) 847
metastasis (846) 846
regulatory t-cells (834) 834
neoplasm staging (809) 809
antigens (778) 778
flow cytometry (757) 757
cell line, tumor (748) 748
cells (732) 732
antigens, neoplasm - immunology (731) 731
apoptosis (719) 719
cell biology (708) 708
neoplasms - therapy (700) 700
interleukin-2 (698) 698
lymphocytes t (698) 698
mice, inbred c57bl (693) 693
gene expression (672) 672
in-vivo (661) 661
therapy (643) 643
surgery (616) 616
immunotherapy - methods (608) 608
melanoma - therapy (591) 591
cytotoxicity, immunologic (588) 588
tumor microenvironment (588) 588
immunotherapy, adoptive (586) 586
treatment outcome (574) 574
health aspects (570) 570
adoptive immunotherapy (568) 568
t-lymphocytes, regulatory - immunology (566) 566
melanoma - pathology (549) 549
medicine & public health (539) 539
antigen (538) 538
lymphocyte activation (530) 530
immunity (529) 529
immune system (528) 528
metastases (527) 527
chemical and pharmacologic phenomena (523) 523
tumor infiltrating lymphocytes (522) 522
t-lymphocyte subsets - immunology (520) 520
lymphocytes, tumor-infiltrating - drug effects (516) 516
medical prognosis (512) 512
cd4-positive t-lymphocytes - immunology (510) 510
cytokines (507) 507
immune response (506) 506
colorectal cancer (498) 498
peripheral-blood (496) 496
activation (490) 490
phenotype (489) 489
breast neoplasms - immunology (483) 483
patients (479) 479
breast-cancer (478) 478
inflammation (469) 469
cytotoxicity (464) 464
breast neoplasms - pathology (454) 454
cd8 antigen (452) 452
identification (447) 447
pd-l1 (438) 438
development and progression (437) 437
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11154) 11154
Chinese (109) 109
French (102) 102
Japanese (69) 69
German (50) 50
Spanish (19) 19
Russian (15) 15
Czech (10) 10
Italian (10) 10
Polish (10) 10
Hungarian (6) 6
Korean (6) 6
Serbian (2) 2
Arabic (1) 1
Finnish (1) 1
Georgian (1) 1
Portuguese (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gut, ISSN 0017-5749, 04/2009, Volume 58, Issue 4, pp. 520 - 529
Background:The antitumoral immune response is one determinant of colorectal cancer (CRC) outcome. Recent work suggests that Foxp3+CD25+CD4+ regulatory T cells... 
PLASMACYTOID DENDRITIC CELLS | REGULATORY-CELLS | SURVIVAL | FOXP3 EXPRESSION | GROWTH-FACTOR-BETA | TGF-BETA | IN-VIVO | DIFFERENTIATION | INTERLEUKIN-6 | GASTROENTEROLOGY & HEPATOLOGY | OVARIAN-CARCINOMA | T-Lymphocyte Subsets - immunology | Adenocarcinoma - pathology | Cell Proliferation | Humans | Middle Aged | Male | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Lymphocyte Activation - immunology | Immune Tolerance - immunology | Aged, 80 and over | Adult | Female | Cytokines - immunology | Neoplasm Invasiveness | Adenocarcinoma - immunology | Immunophenotyping | Colorectal Neoplasms - immunology | Forkhead Transcription Factors - analysis | Lymphocyte Count | Neoplasm Proteins - analysis | Aged | Colorectal Neoplasms - pathology | Neoplasm Staging | Cytokines - biosynthesis | Lymphocytes, Tumor-Infiltrating - immunology | Care and treatment | Immune response | Lymphocytes | Colorectal cancer | Physiological aspects | Development and progression | Research | Proteins | Antigens | Cytokines | Medical prognosis | Software | Experiments | Tumors | Cell adhesion & migration | Adenocarcinoma | Life Sciences | Lymphocytes, Tumor-Infiltrating | Immunology | Neoplasm Proteins | Immunotherapy | T-Lymphocytes, Regulatory | Colorectal Neoplasms | CD4-Positive T-Lymphocytes | T-Lymphocyte Subsets | Lymphocyte Activation | Immune Tolerance | Forkhead Transcription Factors
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 4/2014, Volume 63, Issue 4, pp. 395 - 406
The programmed death-1 (PD-1) molecule is mainly expressed on functionally “exhausted” CD8+ T cells, dampening the host antitumor immune response. We evaluated... 
Immunology | Medicine & Public Health | Oncology | Cancer Research | Breast cancer | Immune evasion | Regulatory T cells | Cancer immunotherapy | PD-1 | APOPTOSIS | PROGNOSIS | TUMOR | RISK | ANTIBODY | IMMUNOLOGY | CHEMOTHERAPY | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | IMMUNOTHERAPY | CD8(+) T-LYMPHOCYTES | B7-H1 | Carcinoma, Lobular - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Programmed Cell Death 1 Receptor - analysis | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Antigens, Differentiation, T-Lymphocyte - analysis | Aged, 80 and over | Carcinoma, Ductal, Breast - pathology | Lymphocytes, Tumor-Infiltrating - chemistry | T-Lymphocytes, Regulatory - chemistry | Carcinoma, Lobular - immunology | CD8-Positive T-Lymphocytes - chemistry | Combined Modality Therapy | Carcinoma, Lobular - radiotherapy | T-Lymphocyte Subsets - pathology | Carcinoma, Ductal, Breast - radiotherapy | Forkhead Transcription Factors - analysis | Survival Analysis | CD8-Positive T-Lymphocytes - immunology | Lymphocytes, Tumor-Infiltrating - immunology | T-Lymphocyte Subsets - immunology | Breast Neoplasms - surgery | CD8-Positive T-Lymphocytes - pathology | Prognosis | Carcinoma, Ductal, Breast - immunology | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | T-Lymphocytes, Cytotoxic - pathology | T-Lymphocyte Subsets - chemistry | Mastectomy | Adult | Female | Radiotherapy, Adjuvant | T-Lymphocytes, Cytotoxic - immunology | Carcinoma, Ductal, Breast - surgery | Carcinoma, Lobular - surgery | Kaplan-Meier Estimate | Disease-Free Survival | Breast Neoplasms - radiotherapy | T-Lymphocytes, Cytotoxic - chemistry | Apoptosis - immunology | Lymphocytes, Tumor-Infiltrating - pathology | Breast Neoplasms - pathology | Lymphocyte Count | Breast Neoplasms - mortality | Aged
Journal Article
Cancer Research, ISSN 0008-5472, 02/2011, Volume 71, Issue 4, pp. 1263 - 1271
The tumor microenvironment includes a complex network of immune T-cell subpopulations. In this study, we systematically analyzed the balance between cytotoxic... 
BREAST-CANCER | SURVIVAL | LUNG-CANCER | FOXP3 EXPRESSION | RECRUITMENT | ONCOLOGY | GASTRIC-CANCER | EOSINOPHILS | MACROPHAGES | CARCINOMA | LYMPHOCYTES | Th1 Cells - pathology | Th1 Cells - physiology | Prognosis | Th2 Cells - physiology | Tissue Array Analysis | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Carcinoma - mortality | Gene Expression Profiling | Th2 Cells - immunology | Th1 Cells - immunology | Colorectal Neoplasms - diagnosis | Lymphocytes, Tumor-Infiltrating - physiology | T-Lymphocytes, Cytotoxic - pathology | Th1 Cells - metabolism | Th17 Cells - metabolism | Forkhead Transcription Factors - metabolism | Microarray Analysis | T-Lymphocytes, Helper-Inducer - immunology | Lymphocytes, Tumor-Infiltrating - metabolism | T-Lymphocytes, Helper-Inducer - pathology | Interleukin-4 - genetics | Th2 Cells - pathology | Th17 Cells - pathology | Colorectal Neoplasms - mortality | T-Lymphocytes, Cytotoxic - immunology | Th17 Cells - physiology | T-Lymphocytes, Helper-Inducer - metabolism | Carcinoma - immunology | Interleukin-4 - metabolism | Carcinoma - diagnosis | Forkhead Transcription Factors - genetics | Th2 Cells - metabolism | T-Lymphocytes, Cytotoxic - physiology | T-Lymphocytes, Helper-Inducer - physiology | Colorectal Neoplasms - immunology | Lymphocytes, Tumor-Infiltrating - pathology | T-Lymphocytes, Cytotoxic - metabolism | Survival Analysis | Th17 Cells - immunology | Carcinoma - genetics | Cohort Studies | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
European Journal of Immunology, ISSN 0014-2980, 07/2016, Volume 46, Issue 7, pp. 1770 - 1782
We previously demonstrated an accumulation of tumor‐reactive CD4+CD8+ double positive (DP) T cells within melanoma‐infiltrating lymphocytes, supporting their... 
IL‐9R | IL‐9 | CD4+CD8+ double‐positive T lymphocyte | TIL | Melanoma | CD4 | IL-9R | CD8 | double-positive T lymphocyte | IL-9 | TH9 CELLS | CD8(+) | INDUCED APOPTOSIS | INTERLEUKIN-9 | RECEPTOR | PERIPHERAL-BLOOD | IMMUNOLOGY | CYTOKINE EXPRESSION | IN-VIVO | CD4(+) CD8(+) double-positive T lymphocyte | GROWTH-FACTOR | LYMPHOCYTES | T-Lymphocyte Subsets - immunology | Apoptosis - drug effects | Humans | CD4-Positive T-Lymphocytes - immunology | Lymphocyte Activation - immunology | Interleukin-9 - pharmacology | Melanoma - genetics | T-Lymphocyte Subsets - drug effects | CD8-Positive T-Lymphocytes - metabolism | Lymphocytes, Tumor-Infiltrating - metabolism | Cytotoxicity, Immunologic - drug effects | Melanoma - metabolism | Receptors, Interleukin-9 - metabolism | Gene Expression | Cytokines - metabolism | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Lymphocytes, Tumor-Infiltrating - drug effects | Melanoma - pathology | Cell Survival - immunology | Apoptosis - immunology | Receptors, Interleukin-9 - genetics | Lymphocyte Activation - drug effects | Melanoma - immunology | T-Lymphocyte Subsets - metabolism | CD8-Positive T-Lymphocytes - drug effects | CD8-Positive T-Lymphocytes - immunology | Interleukin-9 - immunology | CD4-Positive T-Lymphocytes - drug effects | Lymphocytes, Tumor-Infiltrating - immunology | Parrots | T cells | Tumors | Life Sciences | Cancer
Journal Article
Cancer Science, ISSN 1347-9032, 09/2010, Volume 101, Issue 9, pp. 1947 - 1954
Journal Article
Cancer Research, ISSN 0008-5472, 06/2013, Volume 73, Issue 12, pp. 3591 - 3603
Tumor progression is facilitated by regulatory T cells (Treg) and restricted by effector T cells. In this study, we document parallel regulation of CD8(+) T... 
DISTINCT MECHANISMS | ONCOLOGY | PROGRAMMED DEATH-1 | IMMUNE ESCAPE | MYELOID-LEUKEMIA | SYNGENEIC MOUSE MODEL | REGULATORY T | GROWTH-FACTOR | CHRONIC VIRAL-INFECTION | ANTITUMOR-ACTIVITY | HUMAN OVARIAN-CANCER | T-Lymphocytes, Regulatory - metabolism | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antibodies, Blocking - pharmacology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Neoplasms, Experimental - pathology | Flow Cytometry | T-Lymphocytes - metabolism | Neoplasms, Experimental - immunology | CD8-Positive T-Lymphocytes - metabolism | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Cytokines - immunology | Cytokines - metabolism | Cancer Vaccines - administration & dosage | Mice, Inbred C57BL | CD4-Positive T-Lymphocytes - metabolism | Neoplasms, Experimental - therapy | CTLA-4 Antigen - metabolism | Lymphocytes, Tumor-Infiltrating - transplantation | Programmed Cell Death 1 Receptor - metabolism | Combined Modality Therapy | CTLA-4 Antigen - immunology | B7-H1 Antigen - immunology | Cancer Vaccines - immunology | B7-H1 Antigen - metabolism | Animals | Antibodies, Blocking - immunology | T-Lymphocytes - immunology | Mice | Mice, Inbred BALB C | Programmed Cell Death 1 Receptor - immunology | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Lymphocytes, Tumor-Infiltrating - immunology | Tumor Burden - immunology
Journal Article
Journal Article
Journal of Immunology, ISSN 0022-1767, 04/2015, Volume 194, Issue 7, pp. 3475 - 3486
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 06/2011, Volume 108, Issue 26, pp. 10656 - 10661
Journal Article
Pancreas, ISSN 0885-3177, 01/2004, Volume 28, Issue 1, pp. e26 - 31
Journal Article
British Journal of Cancer, ISSN 0007-0920, 04/2015, Volume 112, Issue 9, pp. 1501 - 1509
Journal Article